Infectious agents and lymphoma development: molecular and clinical aspects
. This review is focused on the role of infectious agents in the development of some lymphoma entities. Associations involving bacterial infections mostly regard marginal zone B‐cell lymphomas of mucosa‐associated lymphoid tissue (MALT)‐type. Some paradigmatic examples of these associations include...
Gespeichert in:
| Veröffentlicht in: | Journal of internal medicine 2009-04, Vol.265 (4), p.421-438 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 438 |
|---|---|
| container_issue | 4 |
| container_start_page | 421 |
| container_title | Journal of internal medicine |
| container_volume | 265 |
| creator | Ferreri, A. J. M. Ernberg, I. Copie‐Bergman, C. |
| description | .
This review is focused on the role of infectious agents in the development of some lymphoma entities. Associations involving bacterial infections mostly regard marginal zone B‐cell lymphomas of mucosa‐associated lymphoid tissue (MALT)‐type. Some paradigmatic examples of these associations include the Helicobacter pylori‐related gastric MALT lymphoma and the more recently reported links between Chlamydophila psittaci and ocular adnexal MALT lymphomas and Borrelia burgdorferi and cutaneous MALT lymphomas. The well‐documented association between Epstein–Barr virus infection and related lymphoproliferative disorders are analysed as an example of lymphotropic virus with tumourigenic activity. Molecular, biological and clinical features as well as therapeutic implications of these associations are analysed and future perspectives in this field are discussed. |
| doi_str_mv | 10.1111/j.1365-2796.2009.02083.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_559089</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20542663</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5833-79de972e8eaf296327cc6c2eedb92cd26583c86612482621c2b030bc33afac193</originalsourceid><addsrcrecordid>eNqNkU1P3DAQhi1EVba0fwHlUm5J7XHs2BwqVai0i0Bc6NlynAlkcT4abwr773HYaHts5zIjzzPjmXkJSRjNWLQvm4xxKVIotMyAUp1RoIpnL0dkdUgckxXVIk-lAnpCPoSwoZRxKul7csI0aJULtSLX665Gt236KST2AbttdF2V-F07PPatTSr8g74f2pi5SNreo5u8Hd8Y55uucdYnNgyxRfhI3tXWB_y0-FPy6-r7_eXP9Obux_ry203qhOI8LXSFugBUaGvQkkPhnHSAWJUaXAUyUk5JySBXIIE5KCmnpePc1tYxzU9Juu8bnnGYSjOMTWvHneltY5anpxihEUJTNfPne34Y-98Thq1pm-DQe9thXNvIggoh4_3-BQIVOUjJI6j2oBv7EEasDzMwamaBzMbMOphZBzMLZN4EMi-x9Gz5YypbrP4WLopE4PMC2BCPW4-2c004cMCA86LII_d1zz03Hnf_PYC5vlvfziF_BYi5rIc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20542663</pqid></control><display><type>article</type><title>Infectious agents and lymphoma development: molecular and clinical aspects</title><source>MEDLINE</source><source>IngentaConnect Free/Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ferreri, A. J. M. ; Ernberg, I. ; Copie‐Bergman, C.</creator><creatorcontrib>Ferreri, A. J. M. ; Ernberg, I. ; Copie‐Bergman, C.</creatorcontrib><description>.
This review is focused on the role of infectious agents in the development of some lymphoma entities. Associations involving bacterial infections mostly regard marginal zone B‐cell lymphomas of mucosa‐associated lymphoid tissue (MALT)‐type. Some paradigmatic examples of these associations include the Helicobacter pylori‐related gastric MALT lymphoma and the more recently reported links between Chlamydophila psittaci and ocular adnexal MALT lymphomas and Borrelia burgdorferi and cutaneous MALT lymphomas. The well‐documented association between Epstein–Barr virus infection and related lymphoproliferative disorders are analysed as an example of lymphotropic virus with tumourigenic activity. Molecular, biological and clinical features as well as therapeutic implications of these associations are analysed and future perspectives in this field are discussed.</description><identifier>ISSN: 0954-6820</identifier><identifier>EISSN: 1365-2796</identifier><identifier>DOI: 10.1111/j.1365-2796.2009.02083.x</identifier><identifier>PMID: 19298458</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Biological and medical sciences ; Borrelia ; Borrelia burgdorferi ; Borrelia Infections - complications ; Chlamydia psittaci ; Chlamydophila Infections - complications ; Chlamydophila psittaci ; Cytogenetics ; Epstein-Barr virus ; Epstein-Barr Virus Infections - complications ; General aspects ; Helicobacter ; Helicobacter Infections - complications ; Helicobacter pylori ; Hematologic and hematopoietic diseases ; Herpesvirus 4, Human ; Hodgkin lymphoma ; Humans ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Lymphoma, B-Cell - genetics ; Lymphoma, B-Cell - microbiology ; Lymphoma, B-Cell - pathology ; lymphomagenesis ; MALT‐type lymphoma ; Medical sciences</subject><ispartof>Journal of internal medicine, 2009-04, Vol.265 (4), p.421-438</ispartof><rights>2009 Blackwell Publishing Ltd</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5833-79de972e8eaf296327cc6c2eedb92cd26583c86612482621c2b030bc33afac193</citedby><cites>FETCH-LOGICAL-c5833-79de972e8eaf296327cc6c2eedb92cd26583c86612482621c2b030bc33afac193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2796.2009.02083.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2796.2009.02083.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21233774$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19298458$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:118429647$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Ferreri, A. J. M.</creatorcontrib><creatorcontrib>Ernberg, I.</creatorcontrib><creatorcontrib>Copie‐Bergman, C.</creatorcontrib><title>Infectious agents and lymphoma development: molecular and clinical aspects</title><title>Journal of internal medicine</title><addtitle>J Intern Med</addtitle><description>.
This review is focused on the role of infectious agents in the development of some lymphoma entities. Associations involving bacterial infections mostly regard marginal zone B‐cell lymphomas of mucosa‐associated lymphoid tissue (MALT)‐type. Some paradigmatic examples of these associations include the Helicobacter pylori‐related gastric MALT lymphoma and the more recently reported links between Chlamydophila psittaci and ocular adnexal MALT lymphomas and Borrelia burgdorferi and cutaneous MALT lymphomas. The well‐documented association between Epstein–Barr virus infection and related lymphoproliferative disorders are analysed as an example of lymphotropic virus with tumourigenic activity. Molecular, biological and clinical features as well as therapeutic implications of these associations are analysed and future perspectives in this field are discussed.</description><subject>Biological and medical sciences</subject><subject>Borrelia</subject><subject>Borrelia burgdorferi</subject><subject>Borrelia Infections - complications</subject><subject>Chlamydia psittaci</subject><subject>Chlamydophila Infections - complications</subject><subject>Chlamydophila psittaci</subject><subject>Cytogenetics</subject><subject>Epstein-Barr virus</subject><subject>Epstein-Barr Virus Infections - complications</subject><subject>General aspects</subject><subject>Helicobacter</subject><subject>Helicobacter Infections - complications</subject><subject>Helicobacter pylori</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Herpesvirus 4, Human</subject><subject>Hodgkin lymphoma</subject><subject>Humans</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Lymphoma, B-Cell - genetics</subject><subject>Lymphoma, B-Cell - microbiology</subject><subject>Lymphoma, B-Cell - pathology</subject><subject>lymphomagenesis</subject><subject>MALT‐type lymphoma</subject><subject>Medical sciences</subject><issn>0954-6820</issn><issn>1365-2796</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1P3DAQhi1EVba0fwHlUm5J7XHs2BwqVai0i0Bc6NlynAlkcT4abwr773HYaHts5zIjzzPjmXkJSRjNWLQvm4xxKVIotMyAUp1RoIpnL0dkdUgckxXVIk-lAnpCPoSwoZRxKul7csI0aJULtSLX665Gt236KST2AbttdF2V-F07PPatTSr8g74f2pi5SNreo5u8Hd8Y55uucdYnNgyxRfhI3tXWB_y0-FPy6-r7_eXP9Obux_ry203qhOI8LXSFugBUaGvQkkPhnHSAWJUaXAUyUk5JySBXIIE5KCmnpePc1tYxzU9Juu8bnnGYSjOMTWvHneltY5anpxihEUJTNfPne34Y-98Thq1pm-DQe9thXNvIggoh4_3-BQIVOUjJI6j2oBv7EEasDzMwamaBzMbMOphZBzMLZN4EMi-x9Gz5YypbrP4WLopE4PMC2BCPW4-2c004cMCA86LII_d1zz03Hnf_PYC5vlvfziF_BYi5rIc</recordid><startdate>200904</startdate><enddate>200904</enddate><creator>Ferreri, A. J. M.</creator><creator>Ernberg, I.</creator><creator>Copie‐Bergman, C.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>200904</creationdate><title>Infectious agents and lymphoma development: molecular and clinical aspects</title><author>Ferreri, A. J. M. ; Ernberg, I. ; Copie‐Bergman, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5833-79de972e8eaf296327cc6c2eedb92cd26583c86612482621c2b030bc33afac193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Biological and medical sciences</topic><topic>Borrelia</topic><topic>Borrelia burgdorferi</topic><topic>Borrelia Infections - complications</topic><topic>Chlamydia psittaci</topic><topic>Chlamydophila Infections - complications</topic><topic>Chlamydophila psittaci</topic><topic>Cytogenetics</topic><topic>Epstein-Barr virus</topic><topic>Epstein-Barr Virus Infections - complications</topic><topic>General aspects</topic><topic>Helicobacter</topic><topic>Helicobacter Infections - complications</topic><topic>Helicobacter pylori</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Herpesvirus 4, Human</topic><topic>Hodgkin lymphoma</topic><topic>Humans</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Lymphoma, B-Cell - genetics</topic><topic>Lymphoma, B-Cell - microbiology</topic><topic>Lymphoma, B-Cell - pathology</topic><topic>lymphomagenesis</topic><topic>MALT‐type lymphoma</topic><topic>Medical sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ferreri, A. J. M.</creatorcontrib><creatorcontrib>Ernberg, I.</creatorcontrib><creatorcontrib>Copie‐Bergman, C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Journal of internal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ferreri, A. J. M.</au><au>Ernberg, I.</au><au>Copie‐Bergman, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Infectious agents and lymphoma development: molecular and clinical aspects</atitle><jtitle>Journal of internal medicine</jtitle><addtitle>J Intern Med</addtitle><date>2009-04</date><risdate>2009</risdate><volume>265</volume><issue>4</issue><spage>421</spage><epage>438</epage><pages>421-438</pages><issn>0954-6820</issn><eissn>1365-2796</eissn><abstract>.
This review is focused on the role of infectious agents in the development of some lymphoma entities. Associations involving bacterial infections mostly regard marginal zone B‐cell lymphomas of mucosa‐associated lymphoid tissue (MALT)‐type. Some paradigmatic examples of these associations include the Helicobacter pylori‐related gastric MALT lymphoma and the more recently reported links between Chlamydophila psittaci and ocular adnexal MALT lymphomas and Borrelia burgdorferi and cutaneous MALT lymphomas. The well‐documented association between Epstein–Barr virus infection and related lymphoproliferative disorders are analysed as an example of lymphotropic virus with tumourigenic activity. Molecular, biological and clinical features as well as therapeutic implications of these associations are analysed and future perspectives in this field are discussed.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>19298458</pmid><doi>10.1111/j.1365-2796.2009.02083.x</doi><tpages>18</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0954-6820 |
| ispartof | Journal of internal medicine, 2009-04, Vol.265 (4), p.421-438 |
| issn | 0954-6820 1365-2796 |
| language | eng |
| recordid | cdi_swepub_primary_oai_swepub_ki_se_559089 |
| source | MEDLINE; IngentaConnect Free/Open Access Journals; Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; EZB-FREE-00999 freely available EZB journals |
| subjects | Biological and medical sciences Borrelia Borrelia burgdorferi Borrelia Infections - complications Chlamydia psittaci Chlamydophila Infections - complications Chlamydophila psittaci Cytogenetics Epstein-Barr virus Epstein-Barr Virus Infections - complications General aspects Helicobacter Helicobacter Infections - complications Helicobacter pylori Hematologic and hematopoietic diseases Herpesvirus 4, Human Hodgkin lymphoma Humans Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphoma, B-Cell - genetics Lymphoma, B-Cell - microbiology Lymphoma, B-Cell - pathology lymphomagenesis MALT‐type lymphoma Medical sciences |
| title | Infectious agents and lymphoma development: molecular and clinical aspects |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T05%3A01%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Infectious%20agents%20and%20lymphoma%20development:%20molecular%20and%20clinical%20aspects&rft.jtitle=Journal%20of%20internal%20medicine&rft.au=Ferreri,%20A.%20J.%20M.&rft.date=2009-04&rft.volume=265&rft.issue=4&rft.spage=421&rft.epage=438&rft.pages=421-438&rft.issn=0954-6820&rft.eissn=1365-2796&rft_id=info:doi/10.1111/j.1365-2796.2009.02083.x&rft_dat=%3Cproquest_swepu%3E20542663%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20542663&rft_id=info:pmid/19298458&rfr_iscdi=true |